Rasburicase Injection has been formulated to be administered for treatment of tumor lysis syndrome induced due to chemotherapy for leukemia & lymphomas. It is known to work by removing uric acid from blood by oxidizing it and converting into poorly soluble form. This injection shows no bioavailability with elimination half life of about 18hours. It is a tetrameric protein which is considered to be effective for ovarian cancer and hemorrhagic cystitis. Rasburicase Injection is administered via intravenous route by experienced physician or nurse. It is known to take around 4 hours for lowering plasma uric acid levels below 7.5 mg/dl.
|Minimum Order Quantity||1000 Unit|
|Usage||Commercial, Clinical, Hospital|
Rasburicase Injection exporter, Rasburicase Injection manufacturer
Rasburicase Injection supplier, Rasburicase Injection manufacturer in India,
Rasburicase Injection exporter in India.
ACTIZA PHARMACEUTICAL All Rights Reserved.